FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology, and is intended for treatment of demodectic blepharoconjunctivitis. Method includes processing eyelash edges of patient's eyelids and eyebrows successively with 10% or 5% benzylbenzoate oiltment, uniderm cream, emolium emulsion. Course of treatment includes two 4-day cycles with two-week break. Procedures are carried out two times per day with 6-hour time interval. Intervals between application of medications constitute respectively 15 and 10 minutes.
EFFECT: high penetrating ability of benzylbenzoate in combination with applied medications makes it possible to considerably reduce treatment terms and reduce possibility of recurrences.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION "DEMALAN-AKTIV" FOR DEMODECOSIS TREATMENT | 2006 |
|
RU2313356C1 |
| THERAPY AND PROPHYLAXIS METHOD FOR PREVENTING BLEPHAROCONJUNCTIVITIS RECURRENCE RELATED TO DEMODICOSIS | 2006 |
|
RU2321378C1 |
| METHOD FOR ESTIMATING ACARICIDE PREPARATIONS ACTIVITY IN TREATING THE CASES OF EYE DEMODICOSIS | 2003 |
|
RU2249211C1 |
| METHOD FOR TREATING DEMODECOSIS BLEPHAROCONJUNCTIVITIS | 2003 |
|
RU2254838C1 |
| AGENT FOR TREATMENT OF DEMODECOSEOUS BLEPHAROCONJUNCTIVITIS | 2003 |
|
RU2247572C1 |
| METHOD FOR TREATING BLEPHAROCONJUNCTIVAL DRY EYE SYNDROME FORM CASES | 2006 |
|
RU2312640C1 |
| METHOD OF ACARICIDE TREATMENT OF DEMODECTIC BLEPHAROCONJUNCTIVITIS | 2009 |
|
RU2405505C1 |
| JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
| METHOD OF TREATING BLEPHAROCONJUNCTIVITIS | 2010 |
|
RU2440803C1 |
| GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
